Cargando…
Legumain-induced intracerebrally crosslinked vesicles for suppressing efflux transport of Alzheimer's disease multi-drug nanosystem
Brain barrier is both a protective permeability hurdle and a limitation site where therapeutic agents are excluded to enter the target region. Designing drug vehicle to overcome this notorious barrier bottle is challenging. Herein, we construct a stimuli-responsive self-assembled nanovesicle that de...
Autores principales: | Jiang, Fuxin, Ren, Jian, Gao, Yachai, Wang, Jinna, Zhao, Yiping, Dai, Fengying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718144/ https://www.ncbi.nlm.nih.gov/pubmed/33313452 http://dx.doi.org/10.1016/j.bioactmat.2020.11.024 |
Ejemplares similares
-
Knockdown of Legumain Suppresses Cervical Cancer Cell Migration and Invasion
por: Meng, Fei, et al.
Publicado: (2016) -
Cystatin E/M suppresses legumain activity and invasion of human melanoma
por: Briggs, Jon J, et al.
Publicado: (2010) -
The Asparaginyl Endopeptidase Legumain: An Emerging Therapeutic Target and Potential Biomarker for Alzheimer’s Disease
por: Song, Mingke
Publicado: (2022) -
Nuclear Legumain Activity in Colorectal Cancer
por: Haugen, Mads H., et al.
Publicado: (2013) -
Prognostic value of legumain in uveal melanoma
por: WU, TONG, et al.
Publicado: (2016)